Moxifloxacin in the Prevention of Bacteremia After High-dose Chemotherapy and Transplantation of Peripheral Stem Cells

NCT00398411 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

66

Enrollment

OTHER

Sponsor class

Conditions

Hodgkin Disease
Non-Hodgkin Lymphoma
Multiple Myeloma
Bacteremia

Interventions

DRUG: moxifloxacin
DRUG: placebo

Sponsor

University of Cologne